PubMed

Syngeneic bone marrow transplantation and adoptive transfer of peripheral blood lymphocytes combined with zidovudine in human immunodeficiency virus (HIV) infection.

Lane HC, Zunich KM, Wilson W, Cefali F, Easter M, Kovacs JA, Masur H, Leitman SF, Klein HG, Steis RG, et al.

Ann Intern Med. 1990 Oct 1;113(7):512-9.PMID: 1975487 [PubMed - indexed for MEDLINE]Related articles

The safety and efficacy of zidovudine (AZT) in the treatment of subjects with mildly symptomatic human immunodeficiency virus type 1 (HIV) infection. A double-blind, placebo-controlled trial. The AIDS Clinical Trials Group.

Fischl MA, Richman DD, Hansen N, Collier AC, Carey JT, Para MF, Hardy WD, Dolin R, Powderly WG, Allan JD, et al.

Ann Intern Med. 1990 May 15;112(10):727-37.PMID: 1970466 [PubMed - indexed for MEDLINE]Related articles

Allogeneic bone marrow transplantation, zidovudine, and human immunodeficiency virus type 1 (HIV-1) infection. Studies in a patient with non-Hodgkin lymphoma.

Holland HK, Saral R, Rossi JJ, Donnenberg AD, Burns WH, Beschorner WE, Farzadegan H, Jones RJ, Quinnan GV, Vogelsang GB, et al.

Ann Intern Med. 1989 Dec 15;111(12):973-81.PMID: 2512828 [PubMed - indexed for MEDLINE]Related articles

Safety and efficacy of lamivudine-zidovudine combination therapy in antiretroviral-naive patients. A randomized controlled comparison with zidovudine monotherapy. Lamivudine European HIV Working Group.

Katlama C, Ingrand D, Loveday C, Clumeck N, Mallolas J, Staszewski S, Johnson M, Hill AM, Pearce G, McDade H.

JAMA. 1996 Jul 10;276(2):118-25.PMID: 8656503 [PubMed - indexed for MEDLINE]Related articles

Nevirapine, zidovudine, and didanosine compared with zidovudine and didanosine in patients with HIV-1 infection. A randomized, double-blind, placebo-controlled trial. National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group Protocol 241 Investigators.

D'Aquila RT, Hughes MD, Johnson VA, Fischl MA, Sommadossi JP, Liou SH, Timpone J, Myers M, Basgoz N, Niu M, Hirsch MS.

Ann Intern Med. 1996 Jun 15;124(12):1019-30.PMID: 8633815 [PubMed - indexed for MEDLINE]Related articlesFree article

Zidovudine in patients with human immunodeficiency virus (HIV) infection and Kaposi sarcoma. A phase II randomized, placebo-controlled trial.

Lane HC, Falloon J, Walker RE, Deyton L, Kovacs JA, Masur H, Banks S, Kirk LE, Baseler MW, Salzman NP, et al.

Ann Intern Med. 1989 Jul 1;111(1):41-50. Erratum in: Ann Intern Med 1990 Mar 1;112(5):388. PMID: 2735626 [PubMed - indexed for MEDLINE]Related articles

Interferon-alpha in patients with asymptomatic human immunodeficiency virus (HIV) infection. A randomized, placebo-controlled trial.

Lane HC, Davey V, Kovacs JA, Feinberg J, Metcalf JA, Herpin B, Walker R, Deyton L, Davey RT Jr, Falloon J, et al.

Ann Intern Med. 1990 Jun 1;112(11):805-11.PMID: 1971503 [PubMed - indexed for MEDLINE]Related articles

Combination therapy with zidovudine and dideoxycytidine in patients with advanced human immunodeficiency virus infection. A phase I/II study.

Meng TC, Fischl MA, Boota AM, Spector SA, Bennett D, Bassiakos Y, Lai SH, Wright B, Richman DD.

Ann Intern Med. 1992 Jan 1;116(1):13-20.PMID: 1345755 [PubMed - indexed for MEDLINE]Related articles

Safety and immunogenicity of a candidate therapeutic vaccine, p24 virus-like particle, combined with zidovudine, in asymptomatic subjects. Community HIV Research Network Investigators.

Kelleher AD, Roggensack M, Jaramillo AB, Smith DE, Walker A, Gow I, McMurchie M, Harris J, Patou G, Cooper DA.

AIDS. 1998 Jan 22;12(2):175-82.PMID: 9468366 [PubMed - indexed for MEDLINE]Related articles

Zidovudine in asymptomatic human immunodeficiency virus infection. A controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter. The AIDS Clinical Trials Group of the National Institute of Allergy and Infectious Diseases.

Volberding PA, Lagakos SW, Koch MA, Pettinelli C, Myers MW, Booth DK, Balfour HH Jr, Reichman RC, Bartlett JA, Hirsch MS, et al.

N Engl J Med. 1990 Apr 5;322(14):941-9.PMID: 1969115 [PubMed - indexed for MEDLINE]Related articles

Phase II controlled trial of post-exposure immunization with recombinant gp160 versus antiretroviral therapy in asymptomatic HIV-1-infected adults. VaxSyn Protocol Team.

Pontesilli O, Guerra EC, Ammassari A, Tomino C, Carlesimo M, Antinori A, Tamburrini E, Prozzo A, Seeber AC, Vella S, Ortona L, Aiuti F.

AIDS. 1998 Mar 26;12(5):473-80.PMID: 9543445 [PubMed - indexed for MEDLINE]Related articles

A multicenter trial of oral zidovudine in children with advanced human immunodeficiency virus disease. The Protocol 043 Study Group.

McKinney RE Jr, Maha MA, Connor EM, Feinberg J, Scott GB, Wulfsohn M, McIntosh K, Borkowsky W, Modlin JF, Weintrub P, et al.

N Engl J Med. 1991 Apr 11;324(15):1018-25.PMID: 1672443 [PubMed - indexed for MEDLINE]Related articles

Quantification of HIV-1 virus load under zidovudine therapy in patients with symptomatic HIV infection: relation to disease progression.

Molina JM, Ferchal F, Chevret S, Barateau V, Poirot C, Morinet F, Modai J.

AIDS. 1994 Jan;8(1):27-33.PMID: 7912084 [PubMed - indexed for MEDLINE]Related articles

The duration of zidovudine benefit in persons with asymptomatic HIV infection. Prolonged evaluation of protocol 019 of the AIDS Clinical Trials Group.

Volberding PA, Lagakos SW, Grimes JM, Stein DS, Balfour HH Jr, Reichman RC, Bartlett JA, Hirsch MS, Phair JP, Mitsuyasu RT, et al.

JAMA. 1994 Aug 10;272(6):437-42.PMID: 7913730 [PubMed - indexed for MEDLINE]Related articles

Safety and efficacy of lamivudine-zidovudine combination therapy in zidovudine-experienced patients. A randomized controlled comparison with zidovudine monotherapy. Lamivudine European HIV Working Group.

Staszewski S, Loveday C, Picazo JJ, Dellarnonica P, Skinhøj P, Johnson MA, Danner SA, Harrigan PR, Hill AM, Verity L, McDade H.

JAMA. 1996 Jul 10;276(2):111-7.PMID: 8656502 [PubMed - indexed for MEDLINE]Related articles

A controlled trial of zidovudine in primary human immunodeficiency virus infection.

Kinloch-De Loës S, Hirschel BJ, Hoen B, Cooper DA, Tindall B, Carr A, Saurat JH, Clumeck N, Lazzarin A, Mathiesen L, et al.

N Engl J Med. 1995 Aug 17;333(7):408-13. Erratum in: N Engl J Med 1995 Nov 16;333(20):1367. PMID: 7616989 [PubMed - indexed for MEDLINE]Related articlesFree article

Abacavir-lamivudine-zidovudine vs indinavir-lamivudine-zidovudine in antiretroviral-naive HIV-infected adults: A randomized equivalence trial.

Staszewski S, Keiser P, Montaner J, Raffi F, Gathe J, Brotas V, Hicks C, Hammer SM, Cooper D, Johnson M, Tortell S, Cutrell A, Thorborn D, Isaacs R, Hetherington S, Steel H, Spreen W; CNAAB3005 International Study Team.

JAMA. 2001 Mar 7;285(9):1155-63. Erratum in: JAMA 2001 Jun 13;285(22):2858. PMID: 11231744 [PubMed - indexed for MEDLINE]Related articlesFree article

CD4+ lymphocytes are an incomplete surrogate marker for clinical progression in persons with asymptomatic HIV infection taking zidovudine.

Choi S, Lagakos SW, Schooley RT, Volberding PA.

Ann Intern Med. 1993 May 1;118(9):674-80.PMID: 8096373 [PubMed - indexed for MEDLINE]Related articlesFree article

Treatment with highly active antiretroviral therapy in human immunodeficiency virus type 1-infected children is associated with a sustained effect on growth.

Verweel G, van Rossum AM, Hartwig NG, Wolfs TF, Scherpbier HJ, de Groot R.

Pediatrics. 2002 Feb;109(2):E25.PMID: 11826235 [PubMed - indexed for MEDLINE]Related articlesFree article

Simultaneous vs sequential initiation of therapy with indinavir, zidovudine, and lamivudine for HIV-1 infection: 100-week follow-up.

Gulick RM, Mellors JW, Havlir D, Eron JJ, Gonzalez C, McMahon D, Jonas L, Meibohm A, Holder D, Schleif WA, Condra JH, Emini EA, Isaacs R, Chodakewitz JA, Richman DD.

JAMA. 1998 Jul 1;280(1):35-41.PMID: 9660361 [PubMed - indexed for MEDLINE]Related articlesFree article